Immunic, Inc. (IMUX)
NASDAQ: IMUX · IEX Real-Time Price · USD
1.450
+0.060 (4.32%)
At close: Jul 26, 2024, 4:00 PM
1.390
-0.060 (-4.14%)
After-hours: Jul 26, 2024, 7:44 PM EDT
Immunic Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
77
Market Cap
130.61M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
American Well | 254.57M |
FibroGen | 167.49M |
Agenus | 161.42M |
DIH Holdings US | 64.47M |
BrainsWay | 34.26M |
Inventiva | 25.74M |
IMUX News
- 3 days ago - Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec - PRNewsWire
- 18 days ago - Immunic Appoints Jason Tardio as Chief Operating Officer and President - PRNewsWire
- 2 months ago - Immunic to Participate in Industry and Scientific Conferences in June - PRNewsWire
- 2 months ago - Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 2 months ago - Immunic to Participate in Investor and Scientific Conferences in May - PRNewsWire
- 3 months ago - Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update - PRNewsWire
- 3 months ago - Immunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation - PRNewsWire
- 4 months ago - Immunic to Host MS R&D Day and Participate in Investor Conferences in April - PRNewsWire